NATCO Pharma Buyback 2023 Record Date, Buyback Price, Entitlement Ratio


NATCO Pharma Buyback 2023 description – Natco Pharma is a vertically integrated and R&D-focused pharmaceutical company engaged in developing, manufacturing, and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company’s focus is primarily on niche therapeutic areas and complex products.

It markets and distributes its products in over 40 countries across geographies including the United States, India, Europe, and the rest of the world (RoW). Natco Pharma manufactures API products which are primarily used for captive consumption in its FDF products and are also sold to customers in various international markets such as Brazil, Europe, and the USA.

Natco Pharma is also engaged in the contract manufacturing business, whereby it undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. The company has recently diversified into the business of crop health sciences to leverage its skills in organic chemistry.


NATCO Pharma Buyback 2023 Details

NATCO Pharma Buyback Dates21 Mar – 12 May 2023
NATCO Pharma Buyback Maximum Price INR 700 per share
Market Price on Buyback ApprovalINR 568 per share
Buyback Premium on Market Price23.24%
Buyback Offer Size (Minimum Shares)30,00,000 shares
Buyback Offer Size (Maximum Amount)INR 210 crore
Offer TypeOpen Market (Stock Exchange)
Promoter ParticipationNo
Face Value INR 2 per share
Listing AtBSE, NSE

Buyback Closure Details

Buyback Average PriceINR 609.17 per share
Buyback Offer Size (Shares)34,47,295 shares
Buyback Offer Size (Amount)INR 210 crore

NATCO Pharma Buyback Dates (Timeline)

Board Meeting Intimation for Buyback Proposal2 March 2023
Buyback Approval Date8 March 2023
Public Announcement of Buyback10 March 2023
NATCO Pharma Buyback Record DateNot Applicable
Buyback Opening Date21 March 2023
Buyback Closing Date12 May 2023

NATCO Pharma Buyback 2023 Documents

Completion of Buyback
Public Announcement
Board Approval
Upcoming Share Buyback

NATCO Pharma Buyback Entitlement Ratio

There is no shareholder entitlement since the buyback will be conducted through open market purchases.

NATCO Pharma Financial Performance

FY 2020FY 2021FY 2022
Total Income1,915.02,052.11,944.8
Total Expenses1,453.71,576.11,841.6
Net income 458.1442.4170.0
Figures in INR crore unless specified otherwise

Registrar of NATCO Pharma Buyback 2023

12-10-167, Bharatnagar,
Hyderabad -500018, Andhra Pradesh, India
Phone: 040 23818475
Email: [email protected]

Manager of NATCO Pharma Buyback 2023

One BKC, Tower C,
15th Floor, Unit No.1511,
Bandra Kurla Complex,
Bandra (East), Mumbai 400051
Email: [email protected]

Process to Participate in NATCO Pharma Limited Buyback

Buybacks are conducted either through a tender process or an open market (stock exchanges).

Through Tender Process

All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.

The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.

Through Open Market (Stock Exchanges)

Investor shareholders don’t have to do anything as the company purchases shares through the open market at the prevailing rates and cancels the shares. Since the shares in circulation are reduced by these operations, the fair value of the remaining shares increases, effectively making them more valuable.

Frequently Asked Questions

What are NATCO Pharma Buyback dates?

NATCO Pharma shares Buyback opens on 21 March 2023 and closes on 12 May 2023.

Which type of buyback is NATCO Pharma Buyback offer?

NATCO Pharma Buyback is an open market offer.

What is NATCO Pharma Buyback price?

NATCO Pharma Buyback price is INR 700 per share.

What is NATCO’s Buyback record date?

NATCO Pharma Buyback record date is Not Applicable.

How to participate in NATCO Share Buyback?

NATCO Pharma share buyback will be conducted through open market purchases and thus, no special participation is required from investors.


Please enter your comment!
Please enter your name here